Logo image of UCU.CA

UCORE RARE METALS INC (UCU.CA) Stock Fundamental Analysis

TSX-V:UCU - TSX Venture Exchange - CA90348V3011 - Common Stock - Currency: CAD

1.2  -0.28 (-18.92%)

Fundamental Rating

1

Taking everything into account, UCU scores 1 out of 10 in our fundamental rating. UCU was compared to 808 industry peers in the Metals & Mining industry. Both the profitability and financial health of UCU have multiple concerns. UCU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UCU has reported negative net income.
UCU had a negative operating cash flow in the past year.
UCU had negative earnings in each of the past 5 years.
In the past 5 years UCU always reported negative operating cash flow.
UCU.CA Yearly Net Income VS EBIT VS OCF VS FCFUCU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

UCU's Return On Assets of -23.34% is in line compared to the rest of the industry. UCU outperforms 46.41% of its industry peers.
UCU has a Return On Equity of -35.27%. This is comparable to the rest of the industry: UCU outperforms 48.64% of its industry peers.
Industry RankSector Rank
ROA -23.34%
ROE -35.27%
ROIC N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
UCU.CA Yearly ROA, ROE, ROICUCU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

UCU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UCU.CA Yearly Profit, Operating, Gross MarginsUCU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

UCU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UCU has been increased compared to 5 years ago.
The debt/assets ratio for UCU is higher compared to a year ago.
UCU.CA Yearly Shares OutstandingUCU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
UCU.CA Yearly Total Debt VS Total AssetsUCU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

UCU has an Altman-Z score of -0.12. This is a bad value and indicates that UCU is not financially healthy and even has some risk of bankruptcy.
UCU has a Altman-Z score (-0.12) which is comparable to the rest of the industry.
UCU has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
UCU has a worse Debt to Equity ratio (0.31) than 69.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACCN/A
UCU.CA Yearly LT Debt VS Equity VS FCFUCU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

UCU has a Current Ratio of 0.43. This is a bad value and indicates that UCU is not financially healthy enough and could expect problems in meeting its short term obligations.
UCU's Current ratio of 0.43 is on the low side compared to the rest of the industry. UCU is outperformed by 70.54% of its industry peers.
A Quick Ratio of 0.43 indicates that UCU may have some problems paying its short term obligations.
The Quick ratio of UCU (0.43) is worse than 68.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
UCU.CA Yearly Current Assets VS Current LiabilitesUCU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for UCU have decreased strongly by -11.93% in the last year.
EPS 1Y (TTM)-11.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UCU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UCU.CA Price Earnings VS Forward Price EarningsUCU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UCU.CA Per share dataUCU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UCU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UCORE RARE METALS INC

TSX-V:UCU (6/18/2025, 7:00:00 PM)

1.2

-0.28 (-18.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap89.29M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.22
P/tB 2.72
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS0.54
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.34%
ROE -35.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.85%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z -0.12
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1731.92%
Cap/Depr(5y)1254.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.98%
OCF growth 3YN/A
OCF growth 5YN/A